While the results look promising on paper, this test still needs extensive validation before reaching patients. The study only examined symptomatic women, and real-world performance may differ significantly from controlled research conditions. Additional prospective trials are essential before making bold claims about revolutionizing cancer care.
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.4.1